Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection

Journal of Clinical Oncology

Volumn 19, Issue 7, 2001, Pages 2041-2048

  Morgner, A ^a   Miehlke, S ^a   Fischbach, W ^a   Schmitt, W ^a   Muller Hermelink H ^a   Greiner, A ^a   Thiede, C ^a   Schetelig, J ^a   Neubauer, A ^a   Stolte, M ^a   Ehninger, G ^a   Bayerdorffer E ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; DISEASE COURSE; ERADICATION THERAPY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH LYMPHOMA;

EID: 0035300675     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.7.2041     Document Type: Article

References (44)

1. The MALT lymphoma concept updated
2. Primary B-cell gastric lymphoma: A clinicopathological study of 145 patients
3. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
4. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori
5. Helicobacter pylori specific tumour-infiltrating T-cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue
6. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
7. Gastric MALT lymphoma: From concept to cure
8. Histological grading in gastric lymphoma: Pretreatment criteria and clinical relevance
9. Clinicopathological features of gastric mucosa associated lymphoid tissue (MALT) lymphomas: High grade transformation and comparison with diffuse large B cell lymphomas without MALT lymphoma features
10. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue
11. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
12. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
13. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: Histology, polymerase chain reaction or both?
14. Helicobacter pylori and gastric MALT lymphoma
15. Clinical presentation, diagnosis and treatment of Helicobacter pylori-related gastric lymphoma
16. Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: Follow-up together with sequential molecular studies
17. Remission of primary gastric low-grade MALT lymphoma after cure of Helicobacter pylori infection
18. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma
19. Biology and treatment of MALT lymphoma: The state of the art in 1996
20. Role of Helicobacter pylori eradication in high-grade MALT lymphoma
21. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori
22. Regression of gastric lymphoma with therapy of Helicobacter pylori infection
23. Anti-Helicobacter priori therapy in high-grade mucosa-associated lymphoid tissue lymphoma of the stomach
24. Regression of high-grade B-cell gastric lymphoma after eradication of Helicobacter pylori infection
25. Regression of high-grade gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy
26. Malignant lymphoma of mucosa-associated lymphoid tissue
27. Factors influencing lymph node infiltration in primary gastric malignant lymphoma of the mucosa-associated lymphoid tissue of the stomach
28. Double-blind trial of omeprazole and amoxycillin to cure Helicobacter pylori infection in patients with duodenal ulcers
29. The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies - A randomized double-blind study
30. Klinische stadieneinteilung der nicht-Hodgkin-lymphome
31. A clinicopathologic study of gastric mucosa-associated lymphoid tissue lymphoma
32. Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy
33. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphoma of the mucosa-associated lymphoid tissue (MALT-)type
34. A novel gene, MALT1 at 18q21, is involved in t(11;18)(q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue
35. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphoma
36. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue
37. Bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach
38. BCL10 gene mutation in lymphoma
39. Interstitial deletion of 8(q13;q22) in diffuse large B-cell gastric lymphoma
40. Therapeutic management of stage I-II high-grade primary gastric lymphomas
41. Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas: Differences between high-grade and low-grade cases
42. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: Factors relevant to prognosis
43. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging: MALT Lymphoma Study Group
44. Regression of gastric lymphoma of mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori